Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The impairment of CD3+ T lymphocytes in sentinel lymph node of high-risk cutaneous melanoma patients in stage IIB and IIC.

Journal of pathology and translational medicine·2026
Same author

The Chronic Angioedema Registry: what the first 2 years since the implementation of the global registry have taught us.

Frontiers in allergy·2026
Same author

The Landscape of Ferroptosis-Related Gene Signatures as Molecular Stratification in Triple-Negative Breast Cancer.

Diagnostics (Basel, Switzerland)·2026
Same author

Clinical Impact of Multifocality and Bilaterality on Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.

Diagnostics (Basel, Switzerland)·2026
Same author

Male Breast Cancer in Serbia: A 33-Year Retrospective Cohort Study of Genetic Predisposition, Clinicopathological Features, and Survival Outcomes.

Cancers·2026
Same author

Synchronous Breast and Kidney Carcinomas Following Treatment for Hodgkin's Lymphoma in Young Adulthood: A Case Report and Literature Review.

Journal of clinical medicine·2025

相关实验视频

Updated: Jun 9, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K

辐射诱导的乳腺血管肉瘤 - 一个单一机构的经验.

Marko Buta1,2, Nada Santrac1,2, Milan Zegarac1,2

  • 1School of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia.

Diagnostics (Basel, Switzerland)
|October 25, 2024
PubMed
概括

辐射诱导乳腺血管肉瘤 (RIBAS) 是乳腺癌放射治疗的罕见并发症. 这项研究强调了RIBAS.

关键词:
血管瘤是一种血管瘤.乳腺癌 乳腺癌 乳腺癌照射/辐射疗法预后 预后 预后诱导辐射引起的辐射治疗治疗治疗治疗治疗治疗

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

2.5K

相关实验视频

Last Updated: Jun 9, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

2.5K

科学领域:

  • 在瘤学瘤学.
  • 辐射疗法 辐射疗法
  • 手术瘤学手术瘤学

背景情况:

  • 辐射诱导乳腺血管肉瘤 (RIBAS) 是乳腺癌放射治疗后的一种罕见但严重的不良事件.
  • 在接受乳腺癌辅助放射治疗的患者中,RIBAS的发病率低于0.3%.
  • 由于RIBAS的稀有性,对其呈现,管理和结果的数据有限.

研究的目的:

  • 在专门的癌症中心报告RIBAS的发病率,临床表现,管理策略和结果.
  • 分析治疗结果,包括局部复发,远程转移和整体存活率.
  • 强调及时诊断和彻底的外科治疗对改善患者预后的重要性.

主要方法:

  • 在2013年1月至2024年6月期间接受治疗的10,834名乳腺癌患者的回顾性审查.
  • 纳入标准:乳腺保护性手术,术后辐射,放射治疗后至少3年在照射区域发生血管肉瘤,在诊断时没有远程转移.
  • 发生率,潜伏期,瘤特征,管理,局部复发,远程转移和生存结果的分析.

主要成果:

  • 确定了9名患有RIBAS的女性患者,平均年龄为64岁.
  • 从照射到RIBAS诊断的中位延迟时间为64个月;中位瘤大小为55毫米.
  • 观察到高局部复发率 (77.8%) 和远程转移率 (3名患者). 平均整体生存时间为31个月,3年生存率为15.2%.

结论:

  • RIBAS是一种罕见但越来越多地被认可的乳腺癌放射治疗并发症,其特点是具有侵略性的临床过程.
  • 当地复发率高,强调需要有效的管理策略.
  • 及时诊断和彻底的手术切除具有广泛的边缘对于改善RIBAS患者的结果至关重要.